Profile
Jonas Nilsen was the founder of Practio UK Ltd.
(founded in 2015) and Practio ApS (founded in 2017), where he held the title of Deputy Chairman & Chief Innovation Officer.
He also worked as an Independent Director at Brain+ A from 2018 to 2022.
Dr. Nilsen earned a doctorate degree from the University of Copenhagen.
Former positions of Jonas Nilsen
Companies | Position | End |
---|---|---|
Practio ApS
Practio ApS Medical/Nursing ServicesHealth Services Practio ApS offers vaccination and medical consultancy services. It's offerings include vaccines for Yellow fever, Rabies, Typhoid, Hepatitis A and B, Meningitis, Cholera, and Measles, mumps, and rubella. The company was founded on September 29, 2014 and is headquartered in Copenhagen, Denmark. | Founder | 20/12/2022 |
BRAIN+ A/S | Director/Board Member | 02/09/2022 |
Practio UK Ltd.
Practio UK Ltd. Packaged SoftwareTechnology Services Practio UK Ltd. provides technology services to pharmacies to turn them into healthcare hubs, making safe and affordable healthcare accessible for everyone. The company was founded by Mads Mikkelsen and Jonas Nilsen in 2015 and is headquartered in the United Kingdom. | Founder | - |
Training of Jonas Nilsen
University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BRAIN+ A/S | Technology Services |
Private companies | 2 |
---|---|
Practio UK Ltd.
Practio UK Ltd. Packaged SoftwareTechnology Services Practio UK Ltd. provides technology services to pharmacies to turn them into healthcare hubs, making safe and affordable healthcare accessible for everyone. The company was founded by Mads Mikkelsen and Jonas Nilsen in 2015 and is headquartered in the United Kingdom. | Technology Services |
Practio ApS
Practio ApS Medical/Nursing ServicesHealth Services Practio ApS offers vaccination and medical consultancy services. It's offerings include vaccines for Yellow fever, Rabies, Typhoid, Hepatitis A and B, Meningitis, Cholera, and Measles, mumps, and rubella. The company was founded on September 29, 2014 and is headquartered in Copenhagen, Denmark. | Health Services |
- Stock Market
- Insiders
- Jonas Nilsen